Use of Intravenous Immunoglobulin and Rituximab for the prevention and treatment of antibody-mediated rejection

被引：0
|
作者：
Jordan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
XENOTRANSPLANTATION | 2009年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：330 / 331
页数：2
相关论文
共 50 条
  • [41] Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
    Pineiro, Gaston J.
    De Sousa-Amorim, Erika
    Sole, Manel
    Rios, Jose
    Lozano, Miguel
    Cofan, Frederic
    Ventura-Aguiar, Pedro
    Cucchiari, David
    Revuelta, Ignacio
    Cid, Joan
    Palou, Eduard
    Campistol, Josep M.
    Oppenheimer, Federico
    Rovira, Jordi
    Diekmann, Fritz
    [J]. BMC NEPHROLOGY, 2018, 19
  • [42] Treatment with IVIg and rituximab of chronic antibody-mediated rejection: a single-center experience
    Parissiadis, A.
    Muller, C.
    Cazenave, J. -P.
    Moulin, B.
    Hanau, D.
    Caillard, S.
    [J]. TISSUE ANTIGENS, 2011, 77 (05): : 449 - 449
  • [43] RITUXIMAB AS MONOTHERAPY FOR THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Muller, Yannick
    Ghaleb, Nseir
    Rotman, Samuel
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 553 - 554
  • [44] Indicators of Treatment Responsiveness to Rituximab and Plasmapheresis in Antibody-Mediated Rejection After Kidney Transplantation
    Immenschuh, Stephan
    Zilian, Eva
    Daemmrich, Max E.
    Schwarz, Anke
    Gwinner, Wilfried
    Becker, Jan Ulrich
    Blume, Cornelia A.
    [J]. TRANSPLANTATION, 2015, 99 (01) : 56 - 62
  • [45] Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange.
    Pineiro, G.
    Rovira, J.
    De Sousa-Amorim, E.
    Villarreal, J.
    Sole, M.
    Revuelta, I.
    Lozano, M.
    Palou, E.
    Oppenheimer, F.
    Campistol, J.
    Diekmann, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 328 - 328
  • [46] Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study
    Bachelet, Thomas
    Nodimar, Celine
    Taupin, Jean-Luc
    Lepreux, Sebastien
    Moreau, Karine
    Morel, Delphine
    Guidicelli, Gwendaline
    Couzi, Lionel
    Merville, Pierre
    [J]. CLINICAL TRANSPLANTATION, 2015, 29 (05) : 439 - 446
  • [47] Antibody-mediated rejection: New approaches in prevention and management
    Montgomery, R. A.
    Loupy, A.
    Segev, D. L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 3 - 17
  • [48] Antibody-mediated rejection
    Amore, Alessandro
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (05) : 536 - 542
  • [49] The Use Of Bortezomib And Rituximab For The Treatment Of Antibody Mediated Rejection In Lung Transplantation
    Sriram, S.
    Rusinak, J. D.
    Muralidhar, A.
    Lowery, E. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [50] Complement Inhibition for Prevention and Treatment of Antibody-Mediated Rejection in Renal Allograft Recipients
    Jordan, S. C.
    Choi, J.
    Kahwaji, J.
    Vo, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 806 - 808
12345